Bridgefront Capital, LLC Novo Nordisk A S Transaction History
Bridgefront Capital, LLC
- $278 Million
- Q4 2024
A detailed history of Bridgefront Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bridgefront Capital, LLC holds 3,963 shares of NVO stock, worth $326,273. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,963Holding current value
$326,273% of portfolio
0.12%Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,876Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.64 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.28 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.07 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.04 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...